JHIU
PCRX icon

Janus Henderson Investors US’s Pacira BioSciences PCRX Stock Holding History

Janus Henderson Investors US’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-671,287
Closed -$51.5M – 1192
2015
Q4 		$51.5M Sell
671,287
-238,471
-26% -$13.5M 0.04% 409
2015
Q3 		$37.4M Sell
909,758
-2,376,712
-72% -$146M 0.03% 481
2015
Q2 		$232M Buy
3,286,470
+1,569,892
+91% +$124M 0.19% 137
2015
Q1 		$153M Buy
1,716,578
+565,376
+49% +$57.4M 0.13% 222
2014
Q4 		$102M Buy
1,151,202
+145,347
+14% +$13.7M 0.09% 296
2014
Q3 		$97.5M Buy
1,005,855
+85,758
+9% +$8.34M 0.09% 277
2014
Q2 		$84.5M Buy
+920,097
New +$70.1M 0.08% 309

Other funds holding PCRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Visium Asset Management New York $955M AUM 3.58% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return